干旱区生态环境知识资源中心(Arid): Faecal calprotectin and C-reactive protein levels are associated with long-term clinical and endoscopic outcomes: Analysis of the OASIS open-label extension trial of etrasimod for ulcerative colitis

Arid

	Faecal calprotectin and C-reactive protein levels are associated with long-term clinical and endoscopic outcomes: Analysis of the OASIS open-label extension trial of etrasimod for ulcerative colitis
	Yarur, A.1; Chiorean, M.2; Zhang, J.3; Reinisch, W.4; Vermeire, S.5; Panes, J.6; Peyrin-Biroulet, L.7; Sands, B. E.8; Cabell, C. H.3; Naik, S. U.3; Sandborn, W. J.9
来源期刊	JOURNAL OF CROHNS & COLITIS
ISSN	1873-9946
EISSN	1876-4479
出版年	2020
卷号	14 页码:S555-S556
类型	Meeting Abstract
语种	英语
国家	USA ; Austria ; Belgium ; Spain ; France
收录类别	SCI-E
WOS记录号	WOS:000518803402265
WOS类目	Gastroenterology & Hepatology
WOS研究方向	Gastroenterology & Hepatology
资源类型	期刊论文
条目标识符	http://119.78.100.177/qdio/handle/2XILL650/314927
作者单位	1.Med Coll Wisconsin, Milwaukee, WI 53226 USA; 2.Virginia Mason Med Ctr, Seattle, WA 98101 USA; 3.Arena Pharmaceut, San Diego, CA USA; 4.Med Univ Vienna, Vienna, Austria; 5.Univ Hosp Leuven, Leuven, Belgium; 6.Hosp Clin Barcelona, DIBAPS, CIBERehd, Barcelona, Spain; 7.Lorraine Univ, Dept Gastroenterol, INSERM, U954, Vandoeuvre Les Nancy, France; 8.Icahn Sch Med Mt Sinai, New York, NY 10029 USA; 9.Univ Calif San Diego, La Jolla, CA 92093 USA
推荐引用方式 GB/T 7714	Yarur, A.,Chiorean, M.,Zhang, J.,et al. Faecal calprotectin and C-reactive protein levels are associated with long-term clinical and endoscopic outcomes: Analysis of the OASIS open-label extension trial of etrasimod for ulcerative colitis[J],2020,14:S555-S556.
APA	Yarur, A..,Chiorean, M..,Zhang, J..,Reinisch, W..,Vermeire, S..,...&Sandborn, W. J..(2020).Faecal calprotectin and C-reactive protein levels are associated with long-term clinical and endoscopic outcomes: Analysis of the OASIS open-label extension trial of etrasimod for ulcerative colitis.JOURNAL OF CROHNS & COLITIS,14,S555-S556.
MLA	Yarur, A.,et al."Faecal calprotectin and C-reactive protein levels are associated with long-term clinical and endoscopic outcomes: Analysis of the OASIS open-label extension trial of etrasimod for ulcerative colitis".JOURNAL OF CROHNS & COLITIS 14(2020):S555-S556.